Thompson Siegel & Walmsley’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.5M Buy
69,480
+7,970
+13% +$2.21M 0.32% 81
2025
Q4
$16.9M Sell
61,510
-9,309
-13% -$2.61M 0.28% 95
2025
Q3
$20.4M Buy
70,819
+4,654
+7% +$1.38M 0.33% 85
2025
Q2
$21.9M Buy
66,165
+10,901
+20% +$3.51M 0.36% 79
2025
Q1
$18.2M Buy
55,264
+662
+1% +$199K 0.31% 86
2024
Q4
$15.1M Buy
54,602
+919
+2% +$293K 0.23% 107
2024
Q3
$18.6M Buy
53,683
+63
+0.1% +$21.7K 0.28% 88
2024
Q2
$17.7M Sell
53,620
-225
-0.4% -$77.6K 0.28% 84
2024
Q1
$19.6M Sell
53,845
-30
-0.1% -$9.88K 0.3% 82
2023
Q4
$16.1M Buy
53,875
+93
+0.2% +$27.2K 0.26% 92
2023
Q3
$15.4M Buy
53,782
+394
+0.7% +$112K 0.26% 93
2023
Q2
$15M Sell
53,388
-192
-0.4% -$50K 0.24% 101
2023
Q1
$13.7M Sell
53,580
-3,772
-7% -$1.1M 0.22% 106
2022
Q4
$19M Sell
57,352
-9,179
-14% -$2.9M 0.31% 88
2022
Q3
$18.5M Sell
66,531
-10,234
-13% -$2.88M 0.32% 87
2022
Q2
$20.2M Sell
76,765
-18,224
-19% -$4.7M 0.33% 85
2022
Q1
$22.8M Sell
94,989
-1,533
-2% -$359K 0.32% 90
2021
Q4
$22.2M Sell
96,522
-817
-0.8% -$174K 0.3% 95
2021
Q3
$19.5M Buy
97,339
+8,407
+9% +$1.83M 0.28% 96
2021
Q2
$21.1M Sell
88,932
-859
-1% -$215K 0.29% 93
2021
Q1
$21.7M Sell
89,791
-107
-0.1% -$23.9K 0.31% 87
2020
Q4
$18.7M Sell
89,898
-854
-0.9% -$167K 0.3% 94
2020
Q3
$15.4M Buy
90,752
+3,308
+4% +$582K 0.3% 95
2020
Q2
$16.4M Sell
87,444
-12,550
-13% -$2.38M 0.33% 88
2020
Q1
$17.7M Buy
99,994
+8,707
+10% +$1.69M 0.42% 74
2019
Q4
$18.7M Sell
91,287
-436
-0.5% -$79.9K 0.29% 92
2019
Q3
$13.9M Sell
91,723
-3,936
-4% -$641K 0.22% 99
2019
Q2
$15.1M Buy
95,659
+71
+0.1% +$11.1K 0.22% 95
2019
Q1
$15.4M Sell
95,588
-7,715
-7% -$1.41M 0.22% 104
2018
Q4
$19.6M Buy
103,303
+24,189
+31% +$5.05M 0.31% 91
2018
Q3
$16.5M Sell
79,114
-75
-0.1% -$13.9K 0.21% 111
2018
Q2
$13.5M Buy
79,189
+2,280
+3% +$395K 0.17% 125
2018
Q1
$12.9M Sell
76,909
-3,403
-4% -$661K 0.16% 137
2017
Q4
$16.3M Sell
80,312
-1,577
-2% -$314K 0.19% 121
2017
Q3
$15.3M Sell
81,889
-735
-0.9% -$131K 0.18% 137
2017
Q2
$13.8M Sell
82,624
-27,459
-25% -$4.41M 0.16% 155
2017
Q1
$16.1M Buy
110,083
+27,123
+33% +$4M 0.19% 144
2016
Q4
$11.1M Sell
82,960
-5,511
-6% -$721K 0.15% 185
2016
Q3
$11.5M Sell
88,471
-4,111
-4% -$537K 0.18% 183
2016
Q2
$11.8M Sell
92,582
-370
-0.4% -$48.8K 0.19% 162
2016
Q1
$12.8M Buy
92,952
+665
+0.7% +$91.3K 0.21% 165
2015
Q4
$13.5M Buy
92,287
+363
+0.4% +$49.9K 0.24% 153
2015
Q3
$12.4M Sell
91,924
-6,523
-7% -$947K 0.23% 163
2015
Q2
$15.9M Sell
98,447
-2,050
-2% -$283K 0.28% 134
2015
Q1
$13M Sell
100,497
-195,038
-66% -$22.7M 0.22% 176
2014
Q4
$30.4M Sell
295,535
-54,899
-16% -$5.41M 0.58% 47
2014
Q3
$31.8M Buy
350,434
+4,683
+1% +$438K 0.63% 43
2014
Q2
$31.8M Buy
345,751
+116,908
+51% +$10M 0.62% 43
2014
Q1
$19.2M Buy
228,843
+54,735
+31% +$4.51M 0.43% 88
2013
Q4
$15.2M Buy
174,108
+5,614
+3% +$459K 0.36% 117
2013
Q3
$13M Sell
168,494
-8,924
-5% -$697K 0.28% 155
2013
Q2
$12.9M Buy
+177,418
New +$12M 0.28% 154

Other funds holding CI

Thompson Siegel & Walmsley's CI Position: Q1 2026 in Review

Thompson Siegel & Walmsley increased its Cigna (CI) stake by 13% in Q1 2026, buying an estimated $2.21M and bringing the position to 69,480 shares worth $18.5M. The position accounts for 0.32% of the portfolio, ranked #81.

Thompson Siegel & Walmsley first reported a position in CI in Q2 2013 and has held it in 52 quarters since. The position peaked at $31.8M in Q2 2014. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Thompson Siegel & Walmsley held 69,480 shares of Cigna worth $18.5M as of Q1 2026.
  • Thompson Siegel & Walmsley bought 7,970 Cigna shares in Q1 2026, an estimated $2.21M.
  • Cigna made up 0.32% of Thompson Siegel & Walmsley's portfolio in Q1 2026, its #81 holding.
  • Thompson Siegel & Walmsley first reported a position in Cigna in Q2 2013 and has held it in 52 quarters since.
  • Thompson Siegel & Walmsley's Cigna position peaked at $31.8M in Q2 2014.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Thompson Siegel & Walmsley's 13F filing for Q1 2026, filed 11 May 2026.